Patent · US Active

Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles

US8163557B2 · kind B2 · utility

1Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2008
Grant dateApr 24, 2012
Priority date
Expiry dateJan 27, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/20023
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for producing a chimaeric human papillomavirus (HPV) L1 polypeptide containing a heterologous peptide, and in particular, a HPV L2 peptide comprising the steps of introducing a DNA sequence coding for the heterologous peptide into a DNA sequence coding for the L1 polypeptide; introducing the DNA sequence including the sequences for the L1 polypeptide and heterologous peptide into a host cell in which the DNA sequence can be expressed; causing expression of the DNA sequence; and recovering the resulting chimaeric L1 polypeptide which includes the heterologous peptide. The invention also describes a vector for use in the method, a host cell containing the vector, and a vaccine including the chimaeric HPV L1 polypeptide produced according to the method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.